Study to compare effect of terbinafine alone versus terbinafine with MMR vaccine in case of difficult to treat fungal infection
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2021/03/031654
- Lead Sponsor
- MGM medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
recalcitrant dermatophytosis patients willing to participate in trial
Exclusion Criteria
not willing to participate in trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical cure in dermatophytosisTimepoint: 0 day . 15 day. 30 day , 45 day, 60 day
- Secondary Outcome Measures
Name Time Method Clinical improvement in dermatophytosisTimepoint: 0 day . 15 day. 30 day , 45 day, 60 day